Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117772402 | 11777240 | 2 | F | 20150901 | 20151125 | 20160726 | PER | ES-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK019533 | GLENMARK | RODRIGUEZ JIMENEZ C M, SANCHEZ-COLOMER M G, QUINTANA E F, FERNANDEZ DEL CAMPO C B, DEL MAR GARCIA SAIZ M.. PANCREATITIS BY OMEPRAZOLE. AN ADVERSE DRUG REACTION TO CONSIDER FROM A CLINICAL PERSPECTIVE?.. 27TH CONGRESS OF THE SPANISH SOCIETY FOR CLINICAL PHARMACOLOGY. 2014;115:PP 35 | 12.00 | YR | M | Y | 0.00000 | 20160726 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117772402 | 11777240 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | U | 91672 | ||||||||||
| 117772402 | 11777240 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 91672 | |||||||||||
| 117772402 | 11777240 | 3 | C | MEROPENEM. | MEROPENEM | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 4 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 5 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 6 | C | METAMIZOL | METAMIZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 7 | C | BUPIVACAINE. | BUPIVACAINE | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 8 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 9 | C | VANCOMYCIN | VANCOMYCIN | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 10 | C | PROPOFOL. | PROPOFOL | 1 | UNK | 0 | |||||||||||
| 117772402 | 11777240 | 11 | C | GENTAMICIN. | GENTAMICIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117772402 | 11777240 | 1 | Congenital megacolon |
| 117772402 | 11777240 | 2 | Necrotising fasciitis |
| 117772402 | 11777240 | 3 | Product used for unknown indication |
| 117772402 | 11777240 | 4 | Product used for unknown indication |
| 117772402 | 11777240 | 5 | Product used for unknown indication |
| 117772402 | 11777240 | 6 | Product used for unknown indication |
| 117772402 | 11777240 | 7 | Product used for unknown indication |
| 117772402 | 11777240 | 8 | Product used for unknown indication |
| 117772402 | 11777240 | 9 | Product used for unknown indication |
| 117772402 | 11777240 | 10 | Product used for unknown indication |
| 117772402 | 11777240 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117772402 | 11777240 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117772402 | 11777240 | Off label use | |
| 117772402 | 11777240 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |